background image

Glomerulonephritis Clinical Trials

Find clinical trials for glomerulonephritis. Search for glomerulonephritis clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Belimumab With Rituximab for Primary Membranous Nephropathy

for
Membranous Nephropathy, Nephrotic Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD, Bethesda MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03949855

Phase2, Recruiting
Active & Responsive

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

for
Lupus Nephritis
Location: Columbus OH, Lawrenceville GA, Atlanta GA,
Sponsor: NephroNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225387

Recruiting
Active & Responsive

Lupus Landmark Study: A Prospective Registry and Biorepository

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis,
Location: Boston MA, Worcester MA, Quebec, Manhasset NY,
Sponsor: Lupus Research Alliance

Sex: All

Age: 18 - 70+

Code: NCT05934149

Recruiting
Active & Responsive

Nephrotic Syndrome Study Network

for
Minimal Change Disease (MCD), Membranous Nephropathy,
Location: New Hyde Park NY, The Bronx NY, New York NY,
Sponsor: University of Michigan

Sex: All

Age: 0 - 70+

Code: NCT01209000

Recruiting
Active & Responsive

ASF Alport Patient Registry

for
Alport Syndrome, Thin Basement Membrane Disease,
Location: Scottsdale AZ
Sponsor: Alport Syndrome Foundation

Sex: All

Age: 0+

Code: NCT06526741

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

for
Focal Segmental Glomerulosclerosis, Minimal Change Disease,
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 0+

Code: NCT05650619

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

for
Primary IgA Nephropathy
Location: Sydney, Boston MA, Quebec, Mineola NY, Montreal,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05797610

Phase3, Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting
Active & Responsive

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

for
IgA Nephropathy (IgAN)
Location: Jacksonville FL, Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06676579

Phase2, Recruiting

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

for
Fibrillary Glomerulonephritis
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06295770

Phase2, Recruiting